Diagnostics & Diseases Market Research Reports & Industry Analysis

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Spanish Market Overview Five-year test volume and sales ...

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Spanish Market Overview Five-year test volume and sales ...

... be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, ... growing demand for malignancy assays and the rapid market expansion. US Market Overview Five-year test volume and sales projections ...

... experts from the UK, Germany, Italy, France and Spain, FirstWord’s Oncology Market Access Europe – Payer and Industry Perspectives lays out the current – and growing – challenges facing companies in getting drugs to the European market. Filled with compelling insight into the most pressing issues ranging ...

... in the field of oncology and reimbursement trend. The report presents thorough analysis of the global molecular diagnostics market and its various segments and also provides ...

Complete report $24,500. DataPack (test volumes, sales forecasts, supplier shares) $15,900. 'Coagulation Testing in Transition: Convergence of Regulatory Uncertainty, Technological Advances, and Intensifying Competition Create Opportunities with Significant Upside' is Venture Planning Group's new seven- ...

... tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ... of over 500 companies, universities and research centers developing new tumor markers and detection technologies. Competitive Assessments Extensive strategic assessments ...

... (test volumes, sales forecasts, supplier shares) $7,500. 2014 Clinical Chemistry and Immunodiagnostics Testing in US Hospitals, Commercial Laboratories and Point-of-Care ... suppliers. Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...

... and operating characteristics. Alternative market penetration strategies for instrument and reagent suppliers. Potential market entry barriers and risks. Coagulation Tests Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, ...

New Frontiers in Point-of-Care/POC Coagulation Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of the POC coagulation testing market, including its dynamics, size, growth, regulatory requirements, ...

New Frontiers in Point-of-Care/POC Hematology and Flow Cytometry Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups ... hematology and flow cytometry market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test ...

New Frontiers in Point-of-Care/POC Infectious Disease Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of the POC infections disease testing market, including its dynamics, size, growth, regulatory ...

... are related to almost all the therapeutic protein drug development processes. The cytokine and growth factor related products include antibodies ... improve quality of life. “Cancer Cytokines Therapy Pipeline Analysis” Report Highlights: Cancer Cytokines Therapy Market Overview Marketed Drug Profiles & Patent ...

New Frontiers in the US Point-of-Care/POC Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of theten POC market segments, including their dynamics, size, growth, regulatory requirements, ...

New Frontiers in Ancillary Hospital Location Diagnostic Testing (ER, OR, ICU): Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of POC market segments, including their dynamics, size, growth, regulatory requirements, ...

New Frontiers in Physician Office Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of the physician office market segment, including dynamics, size, growth, regulatory requirements, technological ...

New Frontiers in US Critical Care (ER, OR, ICU) Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new report, which provides comprehensive analysis of POC market segments, including their dynamics, size, growth, regulatory requirements, ...

The Personalized Medicine in Oncology Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the world’s leading healthcare companies in oncology sector. All the deals have been tracked year wise. All the deals ...

... and value of these teams. FirstWord's latest Physician Views poll seeks to gain some insight into how physicians value the role that medical affairs personnel play. Specifically we asked US and EU5-based oncologists: How important they view ...

Complete report $34,200.DataPack (test volumes, sales forecasts, supplier shares) $21,100. New Frontiers in Hematology and Flow Cytometry: Global Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Groups new seven-country report designed to help current suppliers and potential ...

... .DataPack (test volumes, sales forecasts, supplier shares) $12,800. New Frontiers in European Hematology and Flow Cytometry Markets: Business Challenges, Emerging ... Analysis Sales and market share estimates for leading suppliers of hematology and flow cytometry products by country. Specimen, test and sales ...

... $34,500. DataPack (test volumes, sales forecasts, supplier shares) $21,800. New Frontiers in Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive ... emerging during the next five years. The report provides five-year volume and sales forecasts for over 100 clinical ...

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. New Frontiers in the European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new five-countrystrategic analysis of ...

... $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. New Frontiers in the French Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, ... the nextfive years. The report explores future trends in the French market; provides estimates of the specimen, test and sales volumes, ...

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. New Frontiers in theGerman Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new studyof the major business ...

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. New Frontiers in theItalian Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new studyof the major business ...

... 600. DataPack (test volumes, sales forecasts, supplier shares) $4,900. New Frontiers in the Japanese Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, ... the nextfive years. The report explores future trends in the Japanese market; provides estimates of the specimen, test and sales volumes, ...

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. New Frontiers in theSpanish Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new studyof the major business ...

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. New Frontiers in the UK Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new studyof the major business opportunities ...

Complete report $11,500. DataPack (test volumes, sales forecasts, supplier shares) $7,500. New Frontiers in theU.S. Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new studyof the major business ...

Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Land scape is Venture Planning Group’s new seven-country strategic analysis of the major business opportunities ...

Complete report $19,850. DataPack (test volumes, sales forecasts, supplier shares) $12,900. New Frontiers in the European Automated Microbiology Markets: Business Challenges, Emerging Technologies, Competitive Land scape is Venture Planning Group’s new five-country strategic analysis of the major ...

... . DataPack (test volumes, sales forecasts, supplier shares) $4,500. New Frontiers in the French Automated Microbiology Market: Business Challenges, Emerging Technologies ... next five years. The report examines key trends in the French automated microbiology market; reviews current and emerging assays; analyzes ...

... . DataPack (test volumes, sales forecasts, supplier shares) $4,500. New Frontiers in the German Automated Microbiology Market: Business Challenges, Emerging Technologies ... next five years. The report examines key trends in the German automated microbiology market; reviews current and emerging assays; analyzes ...

Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500. New Frontiers in the Italian Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Land scape is Venture Planning Group’s new analysis of the major business opportunities emerging ...

Complete report $8,850. DataPack (test volumes, sales forecasts, supplier shares) $5,700. New Frontiers in the Japanese Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Land scape is Venture Planning Group’s new analysis of the major business opportunities emerging ...

Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500. New Frontiers in theSpanish Automated Microbiology Markets: Business Challenges, Emerging Technologies, Competitive Land scape is Venture Planning Group’s new analysis of the major business opportunities emerging ...

Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500. New Frontiers in theUK Automated Microbiology Markets: Business Challenges, Emerging Technologies, Competitive Land scape is Venture Planning Group’s new analysis of the major business opportunities emerging in ...

Complete report $9,850. DataPack (test volumes, sales forecasts, supplier shares) $6,400. New Frontiers in theU.S. Automated Microbiology Markets: Business Challenges, Emerging Technologies, Competitive Land scape is Venture Planning Group’s new analysis of the major business opportunities emerging in ...

Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Summary New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new seven-country report designed to help current suppliers and ...

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. Summary New Frontiers in the European Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new five-country report designed to help ...

... (test volumes, sales forecasts, supplier shares) $3,950. Summary New Frontiers in the French Coagulation Testing Market: Business Challenges, Emerging Technologies ... emerging business opportunities and develop effective strategies for the French coagulation testing market during the next five years. The ...

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. Summary New Frontiers in the Italian Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new report designed to help current suppliers and ...

Complete report $7,400. DataPack (test volumes, sales forecasts, supplier shares) $4,800. Summary New Frontiers in the Japanese Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new report designed to help current suppliers and ...

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. Summary New Frontiers in the Spanish Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new report designed to help current suppliers and ...

Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. Summary New Frontiers in the UK Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new report designed to help current suppliers and ...

Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200. Summary New Frontiers in the U.S. Coagulation Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape is Venture Planning Group’s new report designed to help current suppliers and ...

... Diseases a) Virology Testing b) HPV Testing c) HAI Testing d) Critical Care Testing 3. Genetic Testing 4. Blood Screening 5. Food Pathogen Testing 6. Tissue Typing ... 128 page report with 87 Figures studies the United States Molecular Diagnostics from 4 view points: 1) Market and Forecast 2) Application Wise ...

... . DataPack (test volumes, sales forecasts, supplier shares) $4,350. New Frontiers in the French Cancer Diagnostics Market: Business Challenges, Emerging Technologies, ... during the nextfive years. The report examines trends in the French cancer diagnostics markets, reviews current and emerging assays; analyzes ...

... . DataPack (test volumes, sales forecasts, supplier shares) $4,350. New Frontiers in the German Cancer Diagnostics Market: Business Challenges, Emerging Technologies, ... during the nextfive years. The report examines trends in the German cancer diagnostics markets, reviews current and emerging assays; analyzes ...